Today, CDC Director Rochelle P. Walensky, M. D. , M. P. H. , signed a note authorizing Novavax monovalent COVID-19 boosters for adults.
This action gives others over the age of 18 the option to get a monovalent booster from Novavax instead of an upgraded (bivalent) booster from Pfizer-BioNTech or Moderna if they have finished vaccination number one but have not yet gained a COVID-19 booster, and if they are unable or unwilling to get mRNA vaccines.
Some may not be able to obtain an mRNA vaccine because of an allergy to a component of a COVID-19 mRNA vaccine, or because of a history of a severe allergic reaction (such as anaphylaxis) after a previous dose of a COVID-19 mRNA vaccine. 19, or the lack of availability of an mRNA vaccine. People over the age of 18 may also decide to get a monovalent booster of Novavax if they don’t want to get mRNA vaccines and wouldn’t get a booster dose otherwise. .
The FDA’s authorization of COVID-19 monovalent boosters and CDC’s advice for use are advances in our nation’s comprehensive vaccination program, one that has helped provide greater coverage for all Americans against illness and death from COVID-19.
For updates on this page, enter your address:
We treat your knowledge seriously. You can review and replace the way we collect data below.